Dr. Manny Villafaña is one of the most successful men in the history of medical innovation, having founded some of the most successful companies in the industry, including Guidant Corp., which was sold to Boston Scientific for more than $27 billion and St. Jude Medical (NYSE:STJ). His most recent venture, Kips Bay Medical was supposed to […]
Kips Bay Medical Inc.
DeviceTalks Exclusive: Medtech legend Manny Villafana on Kips Bay Medical closing
By Scott Wooldridge Last night’s DeviceTalks: Minnesota event in Minneapolis highlighted the risks and rewards of medical device entrepreneurship, contrasting the arcs of Kips Bay Medical (OTC:KIPS) and Aum Cardiovascular. Kips Bay founder & CEO Manny Villafaña, the medtech legend who started Guidant and St. Jude Medical (NYSE:STJ), told MassDevice.com publisher Brian Johnson that the company’s wind-down was precipitated by a […]
Kips Bay Medical shareholders OK shutdown
Kips Bay Medical (OTC:KIPS) shareholders today approved the company’s dissolution, after the Minneapolis-based medical device company’s feasibility trial failed. Kips Bay said in June that it would pull the plug after terminating the Emesh I clinical feasibility trial of its eSVS mesh based on poor 6-month results. Today the company said founder, chairman & CEO Manny Villafaña, the medtech […]
Kips Bay Medical pulls the plug
Kips Bay Medical (OTC:KIPS) said last week it will be liquidating the company after terminating the Emesh I clinical feasibility trial of its eSVS mesh based on poor 6-month results. The company’s board of directors unanimously approved a plan to dissolve the company and return any remaining cash to its stockholders, Minneapolis, Minn.-based Kips Bay said. Kips […]
It doesn’t look good for Kips Bay Medical
Kips Bay turns to founder Villafana | Medtech funding for the week of March 30, 2015
Kips Bay Medical turns to founder Villafana
Kips Bay Medical slashes workforce
Medtech leaders talk mistakes, challenges and opportunities at DeviceTalks
A group of medtech insiders gathered in Boston last night to talk shop, share stories and glean insight from some of the industry’s brightest minds at MassDevice’s DeviceTalks East conference.
Integra Lifesciences gains after FDA OKs plant | Wall Street Beat
Integra LifeSciences (NSDQ:IART) shares are up today after the medical device company revealed that FDA inspectors yesterday cleared a New Jersey plant that was the subject of a 2011 warning letter.
Kips Bay rises on FDA trial approval, despite losses in sales and revenue
Medical device maker Kips Bay Medical (NSDQ:KIPS) saw widening losses and sinking sales during its most recent quarter, but the company marked an important win with FDA approval to complete full enrollment in the U.S. arm of a feasibility study.
